Steven M. Paul, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 30,000 shares at $130.00 ($3.9M) on 2020-02-10, disclosed to the SEC on 2020-02-11.
Open-market sale of $3.9M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KRTX | BUY | 2021-08-18 | $501K | — | Filing → |
| ALNY | SELL | 2020-12-22 | $2.1M | — | Filing → |
| KRTX | SELL | 2020-06-30 | $60.5M | — | Filing → |